Methods and compositions for reducing skin damage
View Patent ↗The Notch signal transduction pathway has been identified as a target for screening and treatment methods for the prevention and/or reduction of short- and long-term UVB-induced skin damage, e.g., the prevention and/or reduction of UVB-induced wrinkles. The invention thus features screening and treatment methods for prevention or reduction of UVB-induced sin damage, and related compositions, e.g., cosmetic compositions.
1. A method of treating skin damage caused by ultraviolet radiation in a subject, the method comprising:
identifying a subject in need of treatment for skin damage caused by ultraviolet radiation; and
administering to the subject a composition comprising an agent that increases Notch pathway activity for the purpose of treating the identified skin damage, wherein the agent is selected from the group consisting of: AG-370, AG-1296 (6,7-dimethoxy-3-phenylquinoxaline), nigericin•Na, cytochalasin D, FCCP (carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone), and SP600125, thereby treating the skin damage in the subject.
2. The method of claim 1 , wherein the composition is administered topically.
3. The method of claim 1 , wherein the Notch is Notch1.
4. The method of claim 1 , wherein the skin damage is caused by UVB radiation.
5. The method of claim 1 , wherein the skin damage is wrinkles.
6. The method of claim 1 , wherein the agent is AG-370.
7. The method of claim 1 , wherein the agent is AG-1296.
8. The method of claim 1 , wherein the agent is nigericin.Na.
9. The method of claim 1 , wherein the agent is SP600125.
10. A method of protecting against skin damage caused by ultraviolet radiation in a subject, the method comprising:
identifying a subject in need of reduction of skin damage caused by ultraviolet radiation; and
administering to the subject a composition comprising an agent that increases Notch pathway activity for the purpose of reducing skin damage in the subject, wherein the agent is selected from the group consisting of: AG-370, AG-1296 (6,7-dimethoxy-3-phenylquinoxaline), cytochalasin D, FCCP (carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone), and SP600125.
11. The method of claim 10 , wherein the agent is administered topically.
12. The method of claim 10 , wherein the Notch is Notch1.
13. The method of claim 10 , wherein the skin damage is caused by UVB radiation.
14. The method of claim 10 , wherein the skin damage is wrinkles.
15. The method of claim 10 , wherein the agent is AG-370.
16. The method of claim 10 , wherein the agent is AG-1296.
17. The method of claim 10 , wherein the agent is SP600125.
18. The method of claim 1 , wherein the agent is cytochalasin D.
19. The method of claim 1 , wherein the agent is FCCP.
20. The method of claim 10 , wherein the agent is cytochalasin D.
21. The method of claim 10 , wherein the agent is FCCP.